FDA Compliance 2012 - Off Label Product Use Discussions in Social Media

This 90-minute webinar will review FDA expectations/ requirements for discussing off label uses of medical products on social media, e.g.,Twitter®, Facebook®, etc. We will also discuss key elements of the FDA's new Draft Guidance, "Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices", Dec 2011.

This webinar will examine the existing requirements on "off-label","unapproved", "unlabeled", or "extra-label" uses, as well as key elements of the FDA's New Draft Guidance, "Responding to Unsolicited Requests for Information About Prescription Drugs and Medical Devices", published in December 2011.